CCL13 and obesity disorder: Furthermore, MCP-4 is a novel biomarker of severe obesity and could play an indirect role in favoring subclinical atherosclerosis in obese patients by influencing the circulating levels of eotaxin-3 and MIP-1b, which are directly related to the main atherosclerosis markers (37).